Funds SureTAC oncology programs toward clinical development and three immunology programs.
- Amount
- $13.4M
- Stage
- Seed
- Announced
- 4 December 2025
- Lead
- Kurma Partners
- Other investors
- Curie Capital, Argobio Studio, Angelini Ventures, Eurazeo, Oncode Bridge Fund, ROM Utrecht Region, Cancer Research Horizons
- Use of funds
- Funds SureTAC oncology programs toward clinical development and three immunology programs.
- Checked
- Announced by the company